Retrospective analysis of the clinical characteristics of adefovir dipivoxil-induced Fanconi's syndrome in the Chinese population.
Sun L, Yi D, Sun W, Wang C.
J Clin Pharm Ther · journal article · DOI 10.1111/jcpt.13154 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för adefovir pivoxil. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
28 hitsAdefovir dipivoxil induces DNA replication stress and augments ATR inhibitor-related cytotoxicity.
Patel A, Seraia E, Ebner D, Ryan AJ.
Int J Cancer · journal article; research support, n.i.h., extramural · DOI 10.1002/ijc.32966Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial.
Li XK, Zhang MX, Shao FZ, Zhou DQ, Xue JD, Liu TJ, Chi XL, Lu BJ, Wang XB, Li Q, Li J, Mao DW, Yang HS, Yang HZ, Zhao WX, Li Y, Zhang GL, Zhao YM, Zou JD, Liu MY, Zhang KK, Yang XZ, Gan DN, Li Y, Zhang P, Li ZG, Li S, Ye YA.
Chin J Integr Med · multicenter study; randomized controlled trial; journal article · DOI 10.1007/s11655-020-3250-0Telbivudine and adefovir dipivoxil combination therapy improves renal function in patients with chronic hepatitis B: A STROBE-compliant article.
Xu Y, Nie ZW.
Medicine (Baltimore) · research-article; journal article; observational study · DOI 10.1097/md.0000000000013430Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis.
Luo Q, Deng Y, Cheng F, Kang J, Zhong S, Zhang D, Zeng W.
Medicine (Baltimore) · meta-analysis; systematic review; review-article; journal article · DOI 10.1097/md.0000000000005578Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.
Lin Y, Pan F, Wang Y, Chen Z, Lin C, Yao L, Zhang X, Zhou R, Pan C.
Oncol Lett · research-article; journal article · DOI 10.3892/ol.2016.5393Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.
Zhong JH, Ke Y, Zhu SL, Wang L, Luo CP, Gong WF, You XM, Ma L, Xiang BD, Li LQ.
Onco Targets Ther · research-article; journal article · DOI 10.2147/ott.s120062Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors.
Wei Z, He JW, Fu WZ, Zhang ZL.
Bone · journal article · DOI 10.1016/j.bone.2016.09.017Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis.
Tian L, Fu Q, Huang F.
Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2016.3623Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection.
Takagi J, Morita H, Ito K, Ohashi T, Hirase S, Ito T, Morishima T, Otake K, Yoneda M.
Intern Med · journal article; case reports · DOI 10.2169/internalmedicine.55.6301Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.
Lee YS, Kim BK, Lee HJ, Dan J.
Clin Orthop Surg · journal article; case reports; case-report · DOI 10.4055/cios.2016.8.2.232[Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].
Duan SH, Bao ZY, Yuan XD, Wang L, Liu MS.
Zhongguo Zhong Xi Yi Jie He Za Zhi · randomized controlled trial; journal articleDe novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.
Yang S, Xing H, Wang Q, Wang X, Liu S, Cheng J.
Ann Clin Microbiol Antimicrob · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12941-016-0138-0Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
Wang GL, Liu Y, Qiu P, Zhou SF, Xu LF, Wen P, Wen JB, Xiao XZ.
Eur Rev Med Pharmacol Sci · research support, non-u.s. gov't; randomized controlled trial; journal articleApplication of ionic liquid to polymorphic transformation of anti-viral/HIV drug adefovir dipivoxil.
An JH, Jin F, Kim HS, Ryu HC, Kim JS, Kim HM, Kiyonga AN, Min DS, Youn W, Kim KH, Jung K.
Arch Pharm Res · journal article · DOI 10.1007/s12272-016-0721-0Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy.
Li X, Jie Y, You X, Shi H, Zhang M, Wu Y, Lin G, Li X, Gao Z, Chong Y.
Int J Clin Exp Med · research-article; journal articleEvolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy.
Wang Y, Liu S, Chen YU, Zheng S, Zhou LI, Hua T, Sui S, Lu F, Duan Z.
Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2015.2855Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation.
Lin RZ, Sun PJ, Tao Q, Yao J, Chen JM, Lu TB.
Eur J Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejps.2015.10.006[Adefovir dipivoxil effects on and related factors of blood phosphorus metabolism in patients with chronic hepatitis B].
Ning H, Li K, Li W, Ding G, Xiao E, Mao Z, Kang Y, Shang J.
Zhonghua Gan Zang Bing Za Zhi · research-article; journal article · DOI 10.3760/cma.j.issn.1007-3418.2015.08.007The curative effect of adefovir dipivoxil treating HBeAg negative chronic hepatitis B and treating HBeAg positive chronic hepatitis B combining interferon α-2b.
Gu J, Sun R, Shen S, Yu Z.
Pak J Pharm Sci · randomized controlled trial; journal articleDeep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy.
Wang Y, Shan X, Liang Z, Shan Y, Huang W, Zhang D, Zen A, Zhou X, Zhao Y, Gong X, Xu G, Zhang X, Chen J, Huang A.
PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0131337Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.
Wang G, Liu Y, Qiu P, Zhou SF, Xu L, Wen P, Wen J, Xiao X.
Drug Des Devel Ther · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.2147/dddt.s73150[Clinical analysis of Fanconi syndrome induced by adefovir dipivoxil].
Zhu H, Yuan X, Tang L, Hu P, Cai D, Ren F, Huang W.
Zhonghua Gan Zang Bing Za Zhi · journal article; case-report · DOI 10.3760/cma.j.issn.1007-3418.2015.04.016Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.
Jia HY, Ding F, Chen JY, Lian JS, Zhang YM, Zeng LY, Xiang DR, Yu L, Hu JH, Yu GD, Cai H, Lu YF, Zheng L, Li LJ, Yang YD.
World J Gastroenterol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3748/wjg.v21.i12.3657Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.
Jiang SW, Yao LP, Hu AR, Hu YR, Chen SX, Xiong T, Gao GS, Liang XY, Ding SX, Weng PJ.
World J Gastroenterol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3748/wjg.v20.i45.17100Effect of hepatitis B virus genotypes on the efficacy of adefovir dipivoxil antiviral therapy.
Wen Z, Zhang H, Zhang M, Tan D, Li Q, Zhang H, Wu P, Deng L.
Hepat Mon · research-article; journal article · DOI 10.5812/hepatmon.10813Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA.
Författaruppgift saknas
Drugs R D · review; journal article · DOI 10.2165/00126839-200203030-00008Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA.
Författaruppgift saknas
Drugs R D · journal article · DOI 10.2165/00126839-199902050-00003